APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pneumococcal Polysaccharide Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast 2026-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchPneumococcal Polysaccharide Vaccine Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Pneumococcal Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Pneumococcal Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pneumococcal Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pneumococcal Polysaccharide Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pneumococcal Polysaccharide Vaccine include Sino Biopharm, Zhifei Biological, Walvax, Merck & Co., Sinovac, Kangtai Bio, Antejin Biotechnology, AIM Bio and Sanofi Pasteur, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pneumococcal Polysaccharide Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pneumococcal Polysaccharide Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pneumococcal Polysaccharide Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pneumococcal Polysaccharide Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pneumococcal Polysaccharide Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pneumococcal Polysaccharide Vaccine sales, projected growth trends, production technology, application and end-user industry.

Pneumococcal Polysaccharide Vaccine Segment by Company

Sino Biopharm

Zhifei Biological

Walvax

Merck & Co.

Sinovac

Kangtai Bio

Antejin Biotechnology

AIM Bio

Sanofi Pasteur

Pfizer

Pneumococcal Polysaccharide Vaccine Segment by Type

PPSV23

PCV13

Others

Pneumococcal Polysaccharide Vaccine Segment by Application

Hospital

Centers for Disease Control and Prevention

Others

Pneumococcal Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pneumococcal Polysaccharide Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pneumococcal Polysaccharide Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. PPSV23 Major Manufacturers Table 3. PCV13 Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Centers for Disease Control and Prevention Major Manufacturers Table 8. Others Major Manufacturers Table 9. Pneumococcal Polysaccharide Vaccine Industry Trends Table 10. Pneumococcal Polysaccharide Vaccine Industry Drivers Table 11. Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges Table 12. Pneumococcal Polysaccharide Vaccine Industry Restraints Table 13. Global Pneumococcal Polysaccharide Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Pneumococcal Polysaccharide Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Pneumococcal Polysaccharide Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2026) Table 17. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2027-2032) Table 18. Global Pneumococcal Polysaccharide Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 19. Global Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (Units) Table 20. Global Pneumococcal Polysaccharide Vaccine Sales by Region (2027-2032) & (Units) Table 21. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021-2026) Table 22. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2027-2032) Table 23. Global Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Pneumococcal Polysaccharide Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Pneumococcal Polysaccharide Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Pneumococcal Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Pneumococcal Polysaccharide Vaccine Manufacturers, Product Type & Application Table 31. Global Pneumococcal Polysaccharide Vaccine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Pneumococcal Polysaccharide Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Pneumococcal Polysaccharide Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2026) Table 38. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2027-2032) Table 39. Global Pneumococcal Polysaccharide Vaccine Sales by Type 2021 VS 2025 VS 2032 (Units) Table 40. Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 41. Global Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (Units) Table 42. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026) Table 43. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2027-2032) Table 44. Global Pneumococcal Polysaccharide Vaccine Price by Type (2021-2026) & (US$/Unit) Table 45. Global Pneumococcal Polysaccharide Vaccine Price by Type (2027-2032) & (US$/Unit) Table 46. Global Pneumococcal Polysaccharide Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2026) Table 50. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2027-2032) Table 51. Global Pneumococcal Polysaccharide Vaccine Sales by Application 2021 VS 2025 VS 2032 (Units) Table 52. Global Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 53. Global Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (Units) Table 54. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2026) Table 55. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2027-2032) Table 56. Global Pneumococcal Polysaccharide Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Pneumococcal Polysaccharide Vaccine Price by Application (2027-2032) & (US$/Unit) Table 58. Sino Biopharm Company Information Table 59. Sino Biopharm Business Overview Table 60. Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Sino Biopharm Pneumococcal Polysaccharide Vaccine Product Portfolio Table 62. Sino Biopharm Recent Development Table 63. Zhifei Biological Company Information Table 64. Zhifei Biological Business Overview Table 65. Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Zhifei Biological Pneumococcal Polysaccharide Vaccine Product Portfolio Table 67. Zhifei Biological Recent Development Table 68. Walvax Company Information Table 69. Walvax Business Overview Table 70. Walvax Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Walvax Pneumococcal Polysaccharide Vaccine Product Portfolio Table 72. Walvax Recent Development Table 73. Merck & Co. Company Information Table 74. Merck & Co. Business Overview Table 75. Merck & Co. Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Merck & Co. Pneumococcal Polysaccharide Vaccine Product Portfolio Table 77. Merck & Co. Recent Development Table 78. Sinovac Company Information Table 79. Sinovac Business Overview Table 80. Sinovac Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sinovac Pneumococcal Polysaccharide Vaccine Product Portfolio Table 82. Sinovac Recent Development Table 83. Kangtai Bio Company Information Table 84. Kangtai Bio Business Overview Table 85. Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Kangtai Bio Pneumococcal Polysaccharide Vaccine Product Portfolio Table 87. Kangtai Bio Recent Development Table 88. Antejin Biotechnology Company Information Table 89. Antejin Biotechnology Business Overview Table 90. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product Portfolio Table 92. Antejin Biotechnology Recent Development Table 93. AIM Bio Company Information Table 94. AIM Bio Business Overview Table 95. AIM Bio Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AIM Bio Pneumococcal Polysaccharide Vaccine Product Portfolio Table 97. AIM Bio Recent Development Table 98. Sanofi Pasteur Company Information Table 99. Sanofi Pasteur Business Overview Table 100. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolio Table 102. Sanofi Pasteur Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Pfizer Pneumococcal Polysaccharide Vaccine Product Portfolio Table 107. Pfizer Recent Development Table 108. North America Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 111. North America Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (Units) Table 112. North America Pneumococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 113. North America Pneumococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 114. North America Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 117. North America Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (Units) Table 118. North America Pneumococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 119. North America Pneumococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 120. North America Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 124. North America Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 125. North America Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (Units) Table 126. North America Pneumococcal Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 127. North America Pneumococcal Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 128. United States Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 129. Canada Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 130. Mexico Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 131. Europe Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 134. Europe Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (Units) Table 135. Europe Pneumococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 136. Europe Pneumococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 137. Europe Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 140. Europe Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (Units) Table 141. Europe Pneumococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 142. Europe Pneumococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Europe Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 147. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 148. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (Units) Table 149. Europe Pneumococcal Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 150. Europe Pneumococcal Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 151. Germany Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 152. France Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 153. U.K. Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 154. Italy Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 155. Russia Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 156. Spain Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 157. Netherlands Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 158. Switzerland Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 159. Sweden Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 160. Poland Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 161. China Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 162. China Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 163. China Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 164. China Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (Units) Table 165. China Pneumococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 166. China Pneumococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 167. China Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 168. China Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 169. China Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 170. China Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (Units) Table 171. China Pneumococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 172. China Pneumococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 173. Asia Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 174. Asia Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 175. Asia Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 176. Asia Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (Units) Table 177. Asia Pneumococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 178. Asia Pneumococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 179. Asia Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 180. Asia Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 181. Asia Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 182. Asia Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (Units) Table 183. Asia Pneumococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 184. Asia Pneumococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 185. Asia Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Asia Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. Asia Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. Asia Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 189. Asia Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 190. Asia Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (Units) Table 191. Asia Pneumococcal Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 192. Asia Pneumococcal Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 193. Japan Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 194. South Korea Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 195. India Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 196. Australia Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 197. Taiwan Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 198. Southeast Asia Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 199. SAMEA Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 200. SAMEA Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 201. SAMEA Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 202. SAMEA Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (Units) Table 203. SAMEA Pneumococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 204. SAMEA Pneumococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 205. SAMEA Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 206. SAMEA Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 207. SAMEA Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 208. SAMEA Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (Units) Table 209. SAMEA Pneumococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 210. SAMEA Pneumococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 211. SAMEA Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. SAMEA Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. SAMEA Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. SAMEA Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 215. SAMEA Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 216. SAMEA Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (Units) Table 217. SAMEA Pneumococcal Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 218. SAMEA Pneumococcal Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 219. Brazil Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Argentina Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Chile Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Colombia Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 223. Peru Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 224. Saudi Arabia Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 225. Israel Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 226. UAE Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 227. Turkey Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 228. Iran Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 229. Egypt Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 230. Key Raw Materials Table 231. Raw Materials Key Suppliers Table 232. Pneumococcal Polysaccharide Vaccine Distributors List Table 233. Pneumococcal Polysaccharide Vaccine Customers List Table 234. Research Programs/Design for This Report Table 235. Authors List of This Report Table 236. Secondary Sources Table 237. Primary Sources List of Figures Figure 1. Pneumococcal Polysaccharide Vaccine Image Figure 2. Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pneumococcal Polysaccharide Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. PPSV23 Image Figure 5. PCV13 Image Figure 6. Others Image Figure 7. Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pneumococcal Polysaccharide Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Centers for Disease Control and Prevention Image Figure 11. Others Image Figure 12. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 14. Global Pneumococcal Polysaccharide Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2032) Figure 17. Global Pneumococcal Polysaccharide Vaccine Sales (2021-2032) & (Units) Figure 18. Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 19. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Pneumococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (Units) Figure 21. Europe Pneumococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (Units) Figure 22. China Pneumococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (Units) Figure 23. Asia (Excluding China) Pneumococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (Units) Figure 24. South America, Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (Units) Figure 25. Global Pneumococcal Polysaccharide Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Pneumococcal Polysaccharide Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2032) Figure 31. Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 32. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2032) Figure 34. Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2032) Figure 37. Global Pneumococcal Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 38. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2032) Figure 40. North America Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 41. North America Pneumococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 42. North America Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 43. North America Pneumococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 44. North America Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 45. North America Pneumococcal Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 46. Europe Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 47. Europe Pneumococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 48. Europe Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 49. Europe Pneumococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 50. Europe Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 51. Europe Pneumococcal Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 52. China Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 53. China Pneumococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 54. China Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 55. China Pneumococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 56. Asia Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 57. Asia Pneumococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 58. Asia Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 59. Asia Pneumococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 60. Asia Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 61. Asia Pneumococcal Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 62. SAMEA Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 63. SAMEA Pneumococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 64. SAMEA Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 65. SAMEA Pneumococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 66. SAMEA Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 67. SAMEA Pneumococcal Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 68. Pneumococcal Polysaccharide Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pneumococcal Polysaccharide Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • PPSV23
  • PCV13
  • Others
Applications
  • Hospital
  • Centers for Disease Control and Prevention
  • Others
Companies covered
  • Sino Biopharm
  • Zhifei Biological
  • Walvax
  • Merck & Co.
  • Sinovac
  • Kangtai Bio
  • Antejin Biotechnology
  • AIM Bio
  • Sanofi Pasteur
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pneumococcal Polysaccharide Vaccine Market by Type
  3. 1.2.1 Global Pneumococcal Polysaccharide Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 PPSV23
  5. 1.2.3 PCV13
  6. 1.2.4 Others
  7. 1.3 Pneumococcal Polysaccharide Vaccine Market by Application
  8. 1.3.1 Global Pneumococcal Polysaccharide Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Centers for Disease Control and Prevention
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pneumococcal Polysaccharide Vaccine Market Dynamics
  1. 2.1 Pneumococcal Polysaccharide Vaccine Industry Trends
  2. 2.2 Pneumococcal Polysaccharide Vaccine Industry Drivers
  3. 2.3 Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 Pneumococcal Polysaccharide Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pneumococcal Polysaccharide Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Region
  3. 3.2.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Pneumococcal Polysaccharide Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pneumococcal Polysaccharide Vaccine Sales by Region
  9. 3.4.1 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Pneumococcal Polysaccharide Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pneumococcal Polysaccharide Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
  6. 4.2.1 Global Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pneumococcal Polysaccharide Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pneumococcal Polysaccharide Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pneumococcal Polysaccharide Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pneumococcal Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pneumococcal Polysaccharide Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Pneumococcal Polysaccharide Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pneumococcal Polysaccharide Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Pneumococcal Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
5 Pneumococcal Polysaccharide Vaccine Market by Type
  1. 5.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Type
  2. 5.1.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pneumococcal Polysaccharide Vaccine Sales by Type
  6. 5.2.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pneumococcal Polysaccharide Vaccine Price by Type
6 Pneumococcal Polysaccharide Vaccine Market by Application
  1. 6.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Application
  2. 6.1.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pneumococcal Polysaccharide Vaccine Sales by Application
  6. 6.2.1 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pneumococcal Polysaccharide Vaccine Price by Application
7 Company Profiles
  1. 7.1 Sino Biopharm
  2. 7.1.1 Sino Biopharm Company Information
  3. 7.1.2 Sino Biopharm Business Overview
  4. 7.1.3 Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sino Biopharm Pneumococcal Polysaccharide Vaccine Product Portfolio
  6. 7.1.5 Sino Biopharm Recent Developments
  7. 7.2 Zhifei Biological
  8. 7.2.1 Zhifei Biological Company Information
  9. 7.2.2 Zhifei Biological Business Overview
  10. 7.2.3 Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zhifei Biological Pneumococcal Polysaccharide Vaccine Product Portfolio
  12. 7.2.5 Zhifei Biological Recent Developments
  13. 7.3 Walvax
  14. 7.3.1 Walvax Company Information
  15. 7.3.2 Walvax Business Overview
  16. 7.3.3 Walvax Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Walvax Pneumococcal Polysaccharide Vaccine Product Portfolio
  18. 7.3.5 Walvax Recent Developments
  19. 7.4 Merck & Co.
  20. 7.4.1 Merck & Co. Company Information
  21. 7.4.2 Merck & Co. Business Overview
  22. 7.4.3 Merck & Co. Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck & Co. Pneumococcal Polysaccharide Vaccine Product Portfolio
  24. 7.4.5 Merck & Co. Recent Developments
  25. 7.5 Sinovac
  26. 7.5.1 Sinovac Company Information
  27. 7.5.2 Sinovac Business Overview
  28. 7.5.3 Sinovac Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sinovac Pneumococcal Polysaccharide Vaccine Product Portfolio
  30. 7.5.5 Sinovac Recent Developments
  31. 7.6 Kangtai Bio
  32. 7.6.1 Kangtai Bio Company Information
  33. 7.6.2 Kangtai Bio Business Overview
  34. 7.6.3 Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Kangtai Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
  36. 7.6.5 Kangtai Bio Recent Developments
  37. 7.7 Antejin Biotechnology
  38. 7.7.1 Antejin Biotechnology Company Information
  39. 7.7.2 Antejin Biotechnology Business Overview
  40. 7.7.3 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product Portfolio
  42. 7.7.5 Antejin Biotechnology Recent Developments
  43. 7.8 AIM Bio
  44. 7.8.1 AIM Bio Company Information
  45. 7.8.2 AIM Bio Business Overview
  46. 7.8.3 AIM Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 AIM Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
  48. 7.8.5 AIM Bio Recent Developments
  49. 7.9 Sanofi Pasteur
  50. 7.9.1 Sanofi Pasteur Company Information
  51. 7.9.2 Sanofi Pasteur Business Overview
  52. 7.9.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolio
  54. 7.9.5 Sanofi Pasteur Recent Developments
  55. 7.10 Pfizer
  56. 7.10.1 Pfizer Company Information
  57. 7.10.2 Pfizer Business Overview
  58. 7.10.3 Pfizer Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Pfizer Pneumococcal Polysaccharide Vaccine Product Portfolio
  60. 7.10.5 Pfizer Recent Developments
8 North America
  1. 8.1 North America Pneumococcal Polysaccharide Vaccine Market Size by Type
  2. 8.1.1 North America Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Pneumococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 8.2 North America Pneumococcal Polysaccharide Vaccine Market Size by Application
  6. 8.2.1 North America Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Pneumococcal Polysaccharide Vaccine Price by Application (2021-2032)
  9. 8.3 North America Pneumococcal Polysaccharide Vaccine Market Size by Country
  10. 8.3.1 North America Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pneumococcal Polysaccharide Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pneumococcal Polysaccharide Vaccine Market Size by Type
  2. 9.1.1 Europe Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Pneumococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Pneumococcal Polysaccharide Vaccine Market Size by Application
  6. 9.2.1 Europe Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Pneumococcal Polysaccharide Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Pneumococcal Polysaccharide Vaccine Market Size by Country
  10. 9.3.1 Europe Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pneumococcal Polysaccharide Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pneumococcal Polysaccharide Vaccine Market Size by Type
  2. 10.1.1 China Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Pneumococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 10.2 China Pneumococcal Polysaccharide Vaccine Market Size by Application
  6. 10.2.1 China Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Pneumococcal Polysaccharide Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pneumococcal Polysaccharide Vaccine Market Size by Type
  2. 11.1.1 Asia Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Pneumococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Pneumococcal Polysaccharide Vaccine Market Size by Application
  6. 11.2.1 Asia Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Pneumococcal Polysaccharide Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Pneumococcal Polysaccharide Vaccine Market Size by Country
  10. 11.3.1 Asia Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pneumococcal Polysaccharide Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pneumococcal Polysaccharide Vaccine Market Size by Type
  2. 12.1.1 SAMEA Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pneumococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Pneumococcal Polysaccharide Vaccine Market Size by Application
  6. 12.2.1 SAMEA Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pneumococcal Polysaccharide Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Pneumococcal Polysaccharide Vaccine Market Size by Country
  10. 12.3.1 SAMEA Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pneumococcal Polysaccharide Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pneumococcal Polysaccharide Vaccine Value Chain Analysis
  2. 13.1.1 Pneumococcal Polysaccharide Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pneumococcal Polysaccharide Vaccine Production Mode & Process
  6. 13.2 Pneumococcal Polysaccharide Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pneumococcal Polysaccharide Vaccine Distributors
  9. 13.2.3 Pneumococcal Polysaccharide Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst